03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Amateur philosophers, bar flies, and eulogists, among others, are known to wistfully observe that no...
Read More >
Your home base for all things healthcare compliance. The Compliance Institute offers the latest upda...
Read More >
In response to the COVID-19 pandemic, the Federal Trade Commission and the Antitrust Division of the...
Read More >
As discussed in the initial article on the new CFIUS regulations, there are two important exceptions...
Read More >
Recently, Colorado’s Department of Labor and Employment (CDLE) proposed certain amendments to the r...
Read More >
The hyper-partisan political warfare in the American health care industry is far from over. But anot...
Read More >